Jeffrey Meyehardt, MD of Harvard Medical School discusses how immunotherapy is being studied and implemented in the treatment of gastric and esophageal cancers at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
How are immunotherapies being studied in gastric and esophageal cancers?
